Pharmaceutical Executive September 13, 2021
In this installment of the Harvard Business School Healthcare Alumni Association (HBSHAA) Q&A series, Landmark Bio CEO Ran Zheng talks to Michael Wong about the value of collaboration over competition with best-in-class partners.
Michael Wong: Scan through nearly any life science firm’s annual report and there will be the inevitable reference to a strategic plan of collaborating with academia, government and other “ecosystem” partners. Still, how does one deploy a governance model where every entity (Harvard, MIT, et. al.)1 is perceived as best-in-class in one manner or another; and are used to competing… and winning in their daily operating model?
Ran Zheng: What is great about this team is that each partner understands that to turn cutting-edge research into breakthrough...
Today's Sponsors
Today's Sponsor